From Molecules to Medicines: Leveraging Artificial Intelligence for Next-Generation Drug Design
DOI:
https://doi.org/10.63053/ijhes.127Keywords:
: Artificial Intelligence, Drug Design, Machine Learning, Deep Learning, Drug Discovery, ADMET, Bioactivity PredictionAbstract
The integration of artificial intelligence (AI) into pharmaceutical research is rapidly transforming the drug discovery and development process. This study investigates the application of machine learning (ML) and deep learning (DL) algorithms in modern drug design, with a particular focus on identifying and optimizing novel bioactive compounds. We utilize curated datasets from reputable sources such as Drug Bank, Chambly, and PubChem, emphasizing molecules with established pharmacokinetic and pharmacodynamics profiles. Several models, including Random Forest, Support Vector Machines, Deep Neural Networks, and Graph Neural Networks, are trained to predict biological activity, ADMET properties, and drug-likeness of candidate molecules. The findings demonstrate that AI-driven models can significantly reduce the time and cost of drug development while enhancing prediction accuracy in early-stage screening. The study proposes a practical AI-based pipeline for identifying promising drug candidates, highlighting its potential to support more efficient and targeted pharmaceutical innovations
References
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20–33. https://doi.org/10.1016/j.jhealeco.2016.01.012
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018). The rise of deep learning in drug discovery. Drug Discovery Today, 23(6), 1241–1250. https://doi.org/10.1016/j.drudis.2018.01.039
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., & Zhao, S. (2019). Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery, 18(6), 463–477. https://doi.org/10.1038/s41573-019-0024-5
Zhou, J., Li, Z., Liu, S., Zhou, Y., Wang, Z., & Wang, Y. (2020). Drug discovery based on deep learning: A comprehensive review. Artificial Intelligence in Life Sciences, 1, 100005. https://doi.org/10.1016/j.ailsci.2020.100005
Schneider, G., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., Zentgraf, M., & Hill, J. E. (2020). Rethinking drug design in the artificial intelligence era. Nature Reviews Drug Discovery, 19(5), 353–364. https://doi.org/10.1038/s41573-019-0050-3
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., Volkov, Y., Zholus, A., Shayakhmetov, R. R., Zhebrak, A., Minaeva, L. I., Zagribelnyy, B. A., Filimonov, A., Oprea, T. I., & Aspuru-Guzik, A. (2019). Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nature Biotechnology, 37(9), 1038–1040. https://doi.org/10.1038/s41587-019-0224-x
Wang, J., Zheng, X., Li, Y., & Wu, Y. (2021). Recent advances in machine learning for drug discovery. Trends in Pharmacological Sciences, 42(5), 399–412. https://doi.org/10.1016/j.tips.2021.03.008
Wang, Y., Yu, B., & Yang, J. (2020). Machine learning for drug discovery: A review. Molecular Informatics, 39(3), 2000131. https://doi.org/10.1002/minf.202000131
Fuchs, J., & Thomas, P. D. (2021). Advances in machine learning for drug discovery. Pharmacology & Therapeutics, 218, 107656. https://doi.org/10.1016/j.pharmthera.2020.107656
Stojanovic, J., & Stojanovic, S. (2020). Predicting the binding affinity of small molecules to protein targets using machine learning algorithms. Journal of Medicinal Chemistry, 63(5), 2011–2020. https://doi.org/10.1021/acs.jmedchem.9b01681
Li, Q., Han, L., & Zhang, Z. (2021). Deep learning for drug discovery: Advances and challenges. Frontiers in Pharmacology, 12, 735654. https://doi.org/10.3389/fphar.2021.735654
Johnson, A. R., & Patel, K. (2020). Predicting protein-ligand interactions with deep learning models. Nature Reviews Drug Discovery, 19(12), 795–804. https://doi.org/10.1038/s41573-020-00089-6
Zhang, L., & Tang, Z. (2020). Molecular generation using GANs in drug discovery. *Molecular Therapy - Methods & Clinical Development
Gaulton, A., et al. (2012). "ChEMBL: a large-scale bioactivity database for drug discovery." Nucleic Acids Research, 40(D1), D1100-D1107.
Kim, S., et al. (2019). "PubChem in 2021: new data content and improved web interfaces." Nucleic Acids Research, 49(D1), D1388-D1395.
Zhang, L., et al. (2018). "Molecular feature-based drug discovery: overview and applications." Drug Discovery Today, 23(5), 950-960.
Vapnik, V. (1998). "Statistical Learning Theory." Wiley-Interscience.
Breiman, L. (2001). "Random forests." Machine Learning, 45(1), 5-32.
LeCun, Y., et al. (2015). "Deep learning." Nature, 521(7553), 436-444.
He, K., et al. (2016). "Deep residual learning for image recognition." Proceedings of the IEEE conference on computer vision and pattern recognition, 770-778.
Xiong, Z., et al. (2020). "DeepChem: A library for deep learning in chemistry." Journal of Chemical Information and Modeling, 60(2), 555-563.
Jin, W., et al. (2020). "Junction Tree Variational Autoencoder: Learning Discrete Structures from Molecules." Journal of Chemical Theory and Computation, 16(8), 4841-4850.
Powers, D. M. W. (2011). "Evaluation: from precision, recall and F-measure to ROC, informedness, markedness & correlation." Journal of Machine Learning Technologies, 2(1), 37-63.
Ochoa, D., et al. (2019). "Experimental validation of drug candidates generated by deep learning models." Pharmaceutical Research, 36(2), 1-10.
Smith, J. A., & Zhang, Y. (2023). Artificial intelligence in drug discovery: A review of recent developments and applications. Journal of Pharmaceutical Sciences, 112(4), 123-135. https://doi.org/10.1016/j.jps.2023.03.021.
Brown, T., & Lee, K. (2022). Comparison of machine learning algorithms for drug discovery applications. Computational Biology, 45(3), 556-567. https://doi.org/10.1093/cb/cbz032
Patel, R., & Gupta, M. (2021). Cross-validation techniques in machine learning for predictive modeling in pharmaceutical applications. Computational Drug Design, 33(2), 245-256. https://doi.org/10.1002/cdd.23458
Lee, H. M., & Wong, S. T. (2022). AI-driven drug prediction and design: Current trends and future directions. Journal of Medicinal Chemistry, 65(11), 7549-7565. https://doi.org/10.1021/jm501253h
Williams, R., & Johnson, D. (2023). Challenges in machine learning for drug discovery: Data scarcity and model interpretability. Drug Discovery Today, 28(5), 100-112. https://doi.org/10.1016/j.drudis.2022.12.012
Jones, M. T., & Thompson, P. (2023). Optimizing neural network performance for drug discovery: Techniques and best practices. Journal of Chemical Information and Modeling, 63(1), 211-225. https://doi.org/10.1021/acs.jcim.2c01311
Zhang, H., & Zhang, R. (2023). Explainability in AI models for drug discovery: A critical review and future perspectives. Frontiers in Pharmacology, 14, 2096. https://doi.org/10.3389/fphar.2023.1062536
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is licensed under a Attribution 4.0 International (CC BY 4.0).
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution - You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions - You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
